Adam Rosenberg

Vorstandsvorsitzender bei Aliada Therapeutics, Inc.

Health Technology

Profil

Adam Rosenberg is currently the Chief Executive Officer and Director at Aliada Therapeutics, Inc. He previously worked as a Director at Ambagon Therapeutics, Inc.

Aktive Positionen von Adam Rosenberg

Unternehmen	Position	Beginn
Aliada Therapeutics, Inc. Aliada Therapeutics, Inc. BiotechnologyHealth Technology Aliada Therapeutics, Inc. is a neuroscience-focused company that aims to overcome the delivery hurdle in large molecule drug development. The company is based in Boston, MA. The company is advancing a generation of CNS therapeutics using its novel BBB crossing platform technology, which can efficiently transport a diverse array of therapeutic cargoes into the brain, resulting in enhanced downstream effectiveness. Aliada Therapeutics was founded by Sanjaya Singh, and the CEO is Adam Rosenberg.	Vorstandsvorsitzender	-

Alle aktiven Positionen von Adam Rosenberg

Ehemalige bekannte Positionen von Adam Rosenberg

Unternehmen	Position	Ende
Ambagon Therapeutics, Inc. Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Adam Rosenberg im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Adam Rosenberg im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Ambagon Therapeutics, Inc. Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA.	Health Technology
Aliada Therapeutics, Inc. Aliada Therapeutics, Inc. BiotechnologyHealth Technology Aliada Therapeutics, Inc. is a neuroscience-focused company that aims to overcome the delivery hurdle in large molecule drug development. The company is based in Boston, MA. The company is advancing a generation of CNS therapeutics using its novel BBB crossing platform technology, which can efficiently transport a diverse array of therapeutic cargoes into the brain, resulting in enhanced downstream effectiveness. Aliada Therapeutics was founded by Sanjaya Singh, and the CEO is Adam Rosenberg.	Health Technology